Strut Health Review 2026: $129/mo — But There's an FDA Warning Letter

Quick verdict

Strut Health pairs some of the cheapest compounded GLP-1 prices we've verified with the most serious regulatory flag in this category. Oral semaglutide lozenges advertise at $99/mo and injectables at $129/mo — but on February 20, 2026 the FDA issued warning letter #721448 over misleading compounded-drug marketing, and no close-out letter was on record as of September 2026. Cheap is real; so is the context.

The FDA warning letter — what it actually says

The FDA reviewed struthealth.com in December 2025 and issued MARCS-CMS warning letter 721448 to Strut Health, LLC (Dallas, TX; CEO Simal Patel, MD) on February 20, 2026. Two findings matter to buyers:

• Labeling: compounded product imagery displayed "Strut" branding, which the FDA said implied Strut itself was the compounder — it is not; dispensing runs through a pharmacy network.
• Marketing claims: phrases like "Generic Zepbound, Mounjaro" and claims that semaglutide/tirzepatide are "the active ingredient in the brand medications" implied the compounded products were FDA-evaluated — they are not.

Context: the letter is an allegation, not a court finding, and it came in a wave that hit 30+ telehealth companies the same month. It does not allege the medication itself is unsafe. Strut's current pages now carry explicit "compounded products are not FDA-approved" disclosures. But as of September 4, 2026, no FDA close-out letter was locatable — treat the matter as unresolved. Strut operates its clinical side through Titan Health, P.A.

Strut pricing — the pages disagree (September 2026)

• Auto-refill discounts (~13–21%) are baked into the headline figures
• $40 pharmacy-transfer fee if you move your prescription outside Strut's preferred network
• Included: physician consultation, dose adjustments, shipping
• Cancellation: allowed with 48-hour notice; reviewers report friction completing it
• Trustpilot ~3.4/5 (~700+ reviews); BBB not accredited (B+/D+ reported, ~9 complaints/3 yrs)

What Strut does well

• Cheapest oral compounded entry: $99/mo lozenge is the lowest needle-free price we track
• Real, non-promo rates: independent verification found $129 injectable holds as an ongoing rate, not a teaser
• Format choice: lozenge or injection, sema and tirz, all 50 states + DC
• Established operator: Strut has run multi-condition telehealth (hair, sexual health, weight) for years — not a pop-up GLP-1 shop

The cons — material ones

• FDA warning letter on record, no close-out letter located
• Self-conflicting prices across its own pages — up to $126/mo disagreement on injectable tirzepatide
• Oral premium without data: the lozenge costs $70/mo more than the injection with zero published absorption or comparative-outcome data
• Reputation is mixed: ~3.4/5 Trustpilot, a fifth of reviews are 1-star; recurring themes are surprise charges and cancellation difficulty
• $40 transfer fee penalizes leaving the preferred pharmacy network

Strut vs cleaner alternatives

Full board: GLP-1 Price Index 2026.

Who should pick Strut

Plausible fit if you:

• Specifically want a compounded lozenge at the lowest entry price and accept the regulatory context
• Want the widest dose-adjustment flexibility on a monthly plan

Skip it if you:

• A clean FDA record is non-negotiable — Trimi, SnagRx, or NexLife are comparably priced without warning letters
• You want FDA-approved oral medication — that's the Wegovy pill at $149, not a compounded lozenge
• You're sensitive to cancellation/billing friction — ~1 in 5 Trustpilot reviews is 1-star

Bottom line

Strut's prices are genuinely low and its format menu is genuinely broad. But an open FDA warning letter over misleading compounded-drug claims is not the kind of flag to gloss over — and its own pricing pages can't agree with each other. If you use it, screenshot your checkout terms, get the pharmacy name in writing, and know the 48-hour cancellation rule before day one.

Affiliate disclosure: This article contains affiliate links. We may earn a commission if you sign up through them, at no extra cost to you. Compounded GLP-1 medications are not FDA-approved as finished products and require a prescription. FDA warning letter #721448 is an allegation, not a court finding. Pricing verified September 2026.